A randomized pilot study of high-dose epirubicin as neoadjuvant chemotherapy in the treatment of cancer of the bilharzial bladder.

MLA

Gad el Mawla, N., et al. “A Randomized Pilot Study of High-Dose Epirubicin as Neoadjuvant Chemotherapy in the Treatment of Cancer of the Bilharzial Bladder.” Annals of Oncology : Official Journal of the European Society for Medical Oncology, vol. 2, no. 2, Feb. 1991, pp. 137–40. EBSCOhost, https://doi.org/10.1093/oxfordjournals.annonc.a057877.

APA

Gad el Mawla, N., Mansour, M. A., Eissa, S., Ali, N. M., Elattar, I., Hamza, M. R., Khaled, H., Habboubi, N., Magrath, I., & Elsebai, I. (1991). A randomized pilot study of high-dose epirubicin as neoadjuvant chemotherapy in the treatment of cancer of the bilharzial bladder. Annals of Oncology : Official Journal of the European Society for Medical Oncology, 2(2), 137–140. https://doi.org/10.1093/oxfordjournals.annonc.a057877

Chicago

Gad el Mawla, N, M A Mansour, S Eissa, N M Ali, I Elattar, M R Hamza, H Khaled, N Habboubi, I Magrath, and I Elsebai. 1991. “A Randomized Pilot Study of High-Dose Epirubicin as Neoadjuvant Chemotherapy in the Treatment of Cancer of the Bilharzial Bladder.” Annals of Oncology : Official Journal of the European Society for Medical Oncology 2 (2): 137–40. doi:10.1093/oxfordjournals.annonc.a057877.